🇺🇸 GKOS — Glaukos Corporation

Salud Compra fuerte
← Volver

Precio actual

233,04 USD

Máx. histórico

242,48

5 días

Caída desde máximo

-3,89%

Rango 52 semanas

80,91 – 248,75

Variación hoy

-2,33%

Cierre anterior

238,61

Rango de hoy

230,00 – 240,76

Volumen hoy

10.706.919

Peor caída histórica

-69,57%

01/08/2019 → 20/03/2020

Recuperado en 299 días

Volatilidad anualizada ⓘ

54,27%

Información
Nombre completo
Glaukos Corporation
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Medical Devices
Empleados
1.094
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
242,46 USD (puede no estar actualizado)
Primera cotización
25/06/2015
Precio actualizado
hace 12 horas
Sobre la empresa

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor. The company also provides iStent infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. In addition, the company develops iLink, a device used for the treatment of keratoconus without the removal of the epithelium; ILution, a platform of cream-based drug formulation applied to the outer surface of the eyelid for drop less transdermal delivery of pharmaceutically active compounds for the treatment of anterior segment eye disorders; and retinal XR platform to treat age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and other posterior segment retinal diseases. It sells its products to ambulatory surgery centers, hospitals, and physician private practices through a direct sales organization, direct sales subsidiaries, and distributors. The company was formerly known as Transdx, Inc. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2024 86,05 87,08 85,04 85,45 -0,05% 2,36% 343.300
15/03/2024 84,79 86,29 84,08 85,49 -0,34% 2,61% 645.500
14/03/2024 87,01 87,52 84,52 85,78 -2,09% 3,45% 369.800
13/03/2024 86,91 89,39 86,80 87,61 +0,70% 2,97% 294.700
12/03/2024 86,38 88,41 85,42 87,00 +0,16% 3,46% 416.700
11/03/2024 87,24 87,74 86,21 86,86 -0,69% 1,75% 288.700
08/03/2024 89,32 90,32 87,45 87,46 -1,63% 3,21% 356.600
07/03/2024 86,22 89,14 85,98 88,91 +3,99% 3,67% 687.300
06/03/2024 84,87 86,23 84,00 85,50 +1,41% 2,63% 373.300
05/03/2024 88,12 88,12 83,90 84,31 -4,80% 4,79% 774.500
04/03/2024 88,97 90,04 87,92 88,56 -0,29% 2,38% 588.200
01/03/2024 88,59 88,89 86,64 88,82 +0,26% 2,55% 853.300
29/02/2024 91,44 91,69 88,30 88,59 -1,61% 3,71% 568.900
28/02/2024 89,88 91,14 88,87 90,04 -0,48% 2,53% 453.000
27/02/2024 91,59 92,83 90,09 90,47 -1,27% 2,99% 332.600
26/02/2024 90,11 91,66 89,61 91,63 +2,30% 2,27% 611.800
23/02/2024 90,37 95,17 88,49 89,57 -2,07% 7,39% 1.195.900
22/02/2024 95,58 95,99 90,61 91,46 -1,43% 5,63% 984.000
21/02/2024 91,14 92,83 90,21 92,79 +0,72% 2,87% 528.600
20/02/2024 92,60 93,14 91,38 92,13 -0,54% 1,90% 467.900
16/02/2024 94,79 96,00 91,96 92,63 -3,62% 4,26% 644.600
15/02/2024 95,39 96,17 93,43 96,11 +1,46% 2,87% 351.300
14/02/2024 94,81 96,27 94,26 94,73 +1,24% 2,12% 398.300
13/02/2024 93,55 95,81 92,50 93,57 -2,87% 3,54% 367.000
12/02/2024 96,15 97,24 95,09 96,33 +0,08% 2,24% 474.100
09/02/2024 96,32 97,02 95,33 96,25 +0,27% 1,75% 308.700
08/02/2024 93,90 96,42 93,90 95,99 +1,79% 2,68% 552.500
07/02/2024 93,42 95,42 92,79 94,30 +1,06% 2,82% 529.000
06/02/2024 91,63 94,77 91,01 93,31 +2,45% 4,10% 369.700
05/02/2024 91,29 91,76 90,72 91,08 -0,94% 1,14% 300.700